Inhibition of TSH-induced hydrogen peroxide production by TNF-α through a sphingomyelinase signaling pathway

American Journal of Physiology - Endocrinology and Metabolism

Volumn 273, Issue 3 36-3, 1997, Pages

  Kimura, Takao ^a   Okajima, Fumikazu ^a,b   Kikuchi, Takashi ^a   Kuwabara, Atsushi ^a   Tomura, Hideaki ^a   Sho, Kimie ^a   Kobayashi, Isao ^a   Kondo, Yoichi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Adenosine 3',5' cyclic monophosphate; Calcium; Ceramide; Phospholipase C; Thyroid

Indexed keywords

HYDROGEN PEROXIDE; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA; DRUG DERIVATIVE; IONOMYCIN; N ACETYLSPHINGOSINE; N-ACETYLSPHINGOSINE; SPHINGOSINE; THAPSIGARGIN; THYROTROPIN;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CELL FUNCTION; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIUM CELL; HORMONAL REGULATION; HORMONE METABOLISM; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; SECOND MESSENGER; THYROID CELL; THYROID HORMONE SYNTHESIS; ANIMAL; CELL LINE; DOSE RESPONSE; DRUG ANTAGONISM; KINETICS; METABOLISM; PHYSIOLOGY; THYROID GLAND;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN PEROXIDE; IONOMYCIN; KINETICS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; THAPSIGARGIN; THYROID GLAND; THYROTROPIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030827911     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.273.3.e638     Document Type: Article

References (30)

1. Bielawska, A., H. M. Crane, D. Liotta, L. Obeid, and Y. A. Hannun. Selectivity of ceramide-mediated biology. J. Biol. Chem. 268: 26226-26232, 1993.
2. Bligh, E. G., and W. J. Dyer. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917, 1959.
3. Boelen, A., M. C. P. Schiphorst, O. Bakker, and W. M. Wiersinga. The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice. J. Endocrinol. 146: 475-483, 1995.
4. Boelen, A., M. C. P. Schiphorst, and W. M. Wiersinga. Soluble cytokine receptors and the low 3,5,3′-triiodothyronine syndrome in patients with nonthyroidal disease. J. Clin. Endocrinol. Metab. 80: 971-976, 1995.
5. Buscema, M., I. Todd, U. Deub, L. Hammond, R. Mirakian, and P. Borrell. Influence of tumor necrosis factor-α on the modulation by interferon-γ of HLA class II molecules in human thyroid cells and its effect on interferon-γ binding. J. Clin. Endocrinol. Metab. 69: 433-439, 1989.
6. Chen, G., A. E. Pekary, and J. M. Hershman. Aging of FRTL-5 rat thyroid cells causes sensitivity to cytotoxicity induced by tumor necrosis factor-α. Endocrinology 121: 863-870, 1992.
7. Chopra, I. J., S. Saane, and G. N. C. Teco. A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illnesses. J. Clin. Endocrinol. Metab. 72: 1112-1116, 1991.
8. Dressler, K. A., S. Mathias, and R. N. Kolesnick. Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255: 1715-1718, 1992.
9. Guibauit, G. G., P. J. Brignac, and M. Zimmer. Homovanillic acid as a fluorometric substrate for oxidative enzymes. Anal. Chem. 40: 190-196, 1968.
10. Hannun, Y. A. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 269: 3125-3128, 1994.
11. Honma, M., T. Sato, J. Takezawa, and M. Ui. An ultrasensitive method for the stimulation on cyclic AMP and cyclic GMP in small volume samples from blood and tissue. Biochem. Med. 18: 257-273, 1977.
12. Kasuga, Y., S. Matsubayashi, F. Akasu, N. Miller, C. Jamieson, and R. Volpe. Effects of recombinant human interleukin-2 and tumor necrosis factor-α with or without interferon-γ on human thyroid tissue from patients with Graves' disease and from normal subjects xenografted into nude mice. J. Clin. Endocrinol. Metab. 72: 1296-1301, 1991.
13. Kim, M., C. Linardic, L. Obeid, and Y. A. Hannun. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor-α and γ-interferon. J. Biol. Chem. 266: 484-489, 1991.
14. 2+ signaling followed by phospholipase-A2 activation and potentiated by an adenosine derivative. Endocrinology 36: 116-123, 1995.
15. Obeid, L. M., C. M. Linardic, L. A. Karolak, and Y. A. Hannun. Programmed cell death induced by ceramide. Science 259: 1769-1771, 1993.
16. 2-purinergic receptor-mediated iodide efflux and phosphoinositide turnover in FRTL-5 cells. Endocrinology 123: 1035-1043, 1988.
17. 2-purinergic receptors are coupled to two signal transduction systems leading to inhibition of cAMP generation and to production of inositol trisphosphate in rat hepatocytes. J. Biol. Chem. 262: 12483-12490, 1987.
18. 3-induced HL-60 cell differentiation. J. Biol. Chem. 265: 15823-15831, 1990.
19. Ongphiphadhanakul, B., S. L. Fang, K. T. Tang, N. A. Patwardhan, and L. E. Braverman. Tumor necrosis factor-α decreases thyrotropin-induced 5′-deiodinase activity in FRTL-5 thyroid cells. Eur. J. Endocrinol. 120: 502-507, 1994.
20. Ozawa, M., K. Sato, D. C. Han, M. Kawakami, T. Tsushima, and K. Shizume. Effects of tumor necrosis factor-α/cachectin on thyroid hormone metabolism in mice. Endocrinology 123: 1461-1467, 1988.
21. Pang, X. P., J. M. Hershman, M. Chung, and A. E. Pekary. Characterization of tumor necrosis factor-α receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology 125: 1783-1788, 1989.
22. Pang, X. P., J. M. Hershman, C. J. Mirell, and A. E. Pekary. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-α. Endocrinology 125: 76-84, 1989.
23. Robbins, J., and J. E. Rall. The effect of thyroid stimulating hormone in acute thyroiditis. J. Clin. Endocrinol. 11: 1106-1115, 1951.
24. 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-α, and interferon-γ in human thyrocytes in suspension culture. J. Clin. Endocrinol. Metab. 70: 1735-1743, 1990.
25. Tamura, H., and M. Ui. Purification and properties of whale thyroid stimulating hormone. J. Biochem. 71: 201-210, 1972.
26. Tang, K. T., L. E. Braverman, and W. J. DeVito. Tumor necrosis factor-α and interferon-γ modulate gene expression of type I 5′-deiodinase, thyroid peroxidase, and thyroglobulin in FRTL-5 rat thyroid cells. Endocrinology 126: 881-888, 1995.
27. Van der Poll, T., J. A. Romijn, W. M. Wiersinga, and H. P. Sauerwein. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J. Clin. Endocrinol. Metab. 71: 1567-1572, 1990.
28. Weetman, A. P., and A. J. Rees. Synergistic effects of recombinant tumor necrosis factor and interferon-γ on rat thyroid cell growth and Ia antigen expression. Immunology 63: 285-289, 1988.
29. Weihl, A. C., G. H. Daniel, E. C. Ridgway, and F. Maloof. Thyroid function tests during the early phase of subacute thyroiditis. J. Clin. Endocrinol. Metab. 44: 1107-1114, 1977.
30. Zakarija, M., and J. M. McKenzie. Influence of cytokines on growth and differentiated function of FRTL-5 cells. Endocrinology 125: 1260-1265, 1989.